安普克
信号转导
化学
脂肪生成
生物化学
脂质代谢
药理学
甾醇调节元件结合蛋白
脂肪酸合酶
蛋白激酶A
代谢途径
激酶
细胞生物学
生物
酶
转录因子
基因
作者
Kaile Zong,Kewei Xu,Xingjiang Zhang,Pan Wang,Zhekun Wang,Shan Yang,Huijuan Li,Hui Ke,Shengsheng He,Yunwei Hu,Yuyo Go,Xi Hui Felicia Chan,Jianxin Wu,Qing Huang
标识
DOI:10.1016/j.jep.2023.116581
摘要
Huangqin Tang (HQT), a famous prescription with the effect of clearing pathogenic heat and detoxifying, was first recorded in "Treatise on Typhoid and Miscellaneous Diseases". It has proved that HQT has good anti-inflammatory and antioxidant effects and can improve acne symptoms clinically. However, the study on the regulation of HQT on sebum secretion which is one of the inducements of acne is not enough.This paper aimed to investigate the mechanisms of HQT in the treatment of skin lipid accumulation by network pharmacology and validating the results via in vitro experiments.Network pharmacology was employed to predict the potential targets of HQT against sebum accumulation. Then, the palmitic acid (PA)-induced SZ95 cell model was established to evaluate the effect of HQT on lipid accumulation and anti-inflammation, and the core pathways predicted by network pharmacology were verified in cell studies.336 chemical compounds and 368 targets in HQT were obtained by network pharmacology, of which 65 targets were related to sebum synthesis. 12 core genes were revealed by protein-protein interaction (PPI) network analysis. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment results suggested that AMP-activated protein kinase (AMPK) signaling pathway might play a crucial role in regulating lipogenesis. In vitro experiments, HQT suppressed lipid accumulation, downregulated the expressions of sterol-regulatory element binding protein-1 (SREBP-1) and fatty acid synthase (FAS), and upregulated AMPK phosphorylation. Furthermore, AMPK inhibitor reversed HQT-mediated sebosuppressive effect.The results disclosed that HQT ameliorates lipogenesis in PA-induced SZ95 sebocytes partially through the AMPK signaling pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI